BPC-157 ARG 500mcg – 50 tablets. Premium research grade peptide formulation with consistent dosing and secure packaging.
Format50 Tablets
Concentration500mcg
Pack Size Selected: Single Pack
Pay with Interac e-Transfer or Crypto
HPLC verified. COA on file for this batch
Ships from within Canada; No Customs
Discreet plain packaging; always
24h dispatch; Tracked Delivery
BPC-157 ARG is the arginine salt form of BPC-157 (Body Protection Compound 157), a synthetic pentadecapeptide derived from a protein found naturally in gastric juice. F40 Biotech’s formulation delivers 500mcg per tablet in a 50 count oral format. The arginine salt modification being the critical chemical distinction that makes this oral tablet presentation pharmacologically viable where standard BPC-157 acetate form oral administration is not.
The arginine salt modification addresses the fundamental gastrointestinal stability limitation of standard BPC-157. In its acetate form, BPC-157 is highly susceptible to degradation by gastric acid and gastrointestinal enzymes, a vulnerability that has historically made injectable administration the preferred research delivery route. The arginine salt formation significantly improves resistance to gastric acid degradation and enhances intestinal absorption, delivering meaningful quantities of intact peptide to systemic circulation following oral administration. This stability improvement makes BPC-157 ARG the formulation of choice for research examining oral BPC-157 delivery specifically. It positions it as a distinct research subject from injectable BPC-157 in comparative oral versus parenteral bioavailability studies.
F40 Biotech formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD’s BPC-157 range now spans the most comprehensive delivery format selection of any peptide in our catalogue: F40 Biotech ARG 500mcg oral tablets, iLab Pharma 5mg injectable vial, iLab Pharma 20mg lyophilized vial, Hudson Science 5mg nasal spray, Hudson Science 5 pack 10mg vials, iLab Pharma 10 pack 10mg vials, and inclusion across the Wolverine and KLOW combination formats. Giving researchers every delivery route and concentration option from a single verified Canadian supplier. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Store in a cool, dry place away from direct light and heat. Refrigeration recommended for long term storage. Intended for research purposes only.
Commonly researched alongside TB-500 in tissue repair and recovery protocols. Browse CSD’s full peptide range for complete sourcing.
This BPC-157 Arginate tablet is manufactured by F-40 Biotech; a verified domestic Canadian supplier producing research compounds to CSD's quality standards. All F-40 Biotech products stocked by CSD are independently HPLC tested by accredited third party laboratories before listing, confirming compound identity as BPC-157 arginate salt and tablet dose accuracy at 500mcg per tablet. A certificate of analysis is available on request for this specific lot number.
BPC-157 ARG is the arginate salt form of BPC-157 (Body Protection Compound 157); a stabilized oral formulation specifically developed to survive the gastrointestinal environment and achieve systemic bioavailability via oral administration. Standard BPC-157 acetate used in injectable lyophilized vials has very poor oral bioavailability due to degradation by gastric acid and digestive enzymes. The arginate salt modification provides significantly greater stability in the acidic gastric environment, allowing meaningful oral absorption and systemic distribution. F-40 Biotech's BPC-157 ARG tablets represent a convenient needle free alternative to subcutaneous BPC-157 injection for researchers investigating systemic and gastrointestinal tissue repair effects.
BPC-157 is studied for its regenerative effects on multiple tissue types through upregulation of growth hormone receptor expression, VEGF mediated angiogenesis, and nitric oxide system modulation. The oral tablet format is particularly relevant for gastrointestinal research applications; where oral BPC-157 delivers the compound directly to the gut mucosa for local tissue repair effects alongside systemic absorption. Research applications include gastrointestinal tract healing, leaky gut, inflammatory bowel conditions, tendon and ligament repair, muscle healing, and neurological protection.
BPC-157 ARG tablets are taken orally swallowed with water, typically on an empty stomach for optimal absorption. Common research doses range from 250–500mcg per administration, one to two times daily. A single 500mcg tablet covers the upper end of the common daily research dose, while half a tablet covers conservative 250mcg dosing. The 50 tablet pack provides 25,000mcg total, sufficient for 25–50 days of research at 500mcg once daily. Taking tablets in the morning on an empty stomach is the most common research administration approach for systemic effects.
Yes! This F-40 Biotech batch has been independently HPLC tested by an accredited third party laboratory confirming compound identity as BPC-157 arginate salt and dose accuracy at 500mcg per tablet. A certificate of analysis is available.
